{"text": "such as weight gain, metabolic changes, and cardiovascular problems, in\n\nobese patients treated with antipsychotics (Kaplan et al., 2017).\n\nEfficacy of Antipsychotics in Obese Patients\n\nResearch has also investigated the efficacy of antipsychotics in obese patients.\n\nA study on risperidone found that obese patients had similar treatment\n\nresponse rates compared to non-obese patients (Kaplan et al., 2017). However,\n\nanother study on aripiprazole reported lower efficacy in obese patients\n\ncompared to non-obese patients.", "embedding": []}